NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) — PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, submitted a patent filing with the U.S. …
View the original article here: PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
The article was originally posted on Google News.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.